• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗肿瘤效应B细胞通过Fas/FasL途径直接杀伤肿瘤细胞,并受白细胞介素-10调控。

Antitumor effector B cells directly kill tumor cells via the Fas/FasL pathway and are regulated by IL-10.

作者信息

Tao Huimin, Lu Lin, Xia Yang, Dai Fu, Wang Yi, Bao Yangyi, Lundy Steven K, Ito Fumito, Pan Qin, Zhang Xiaolian, Zheng Fang, Shu Guoshun, Fang Bingmu, Jiang Jinhong, Xia Jianchuang, Huang Shiang, Li Qiao, Chang Alfred E

机构信息

Department of Surgery, University of Michigan, , Ann Arbor, MI, USA; Hubei Province Stem Cell Research and Appling Center, Institute of Hematology, , Union Hospital, , Tongji Medical College, , Huazhong University of Science and Technology, Wuhan, China.

出版信息

Eur J Immunol. 2015 Apr;45(4):999-1009. doi: 10.1002/eji.201444625. Epub 2015 Jan 21.

DOI:10.1002/eji.201444625
PMID:25545618
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4414939/
Abstract

We have previously reported that adoptive transfer of tumor-draining lymph node (TDLN) B cells confers tumor regression in a spontaneous pulmonary metastasis mouse model of breast cancer. In this study, we identified IL-10-producing cells within these B cells, and found that IL-10 removal, either by using IL-10(-/-) TDLN B cells or by systemic neutralization of IL-10, significantly augmented the therapeutic efficacy of adoptively transferred TDLN B cells. Depletion of IL-10 in B-cell adoptive transfers significantly increased CTLs and B-cell activity of PBMCs and splenic cells in the recipient. Activated TDLN B cells express Fas ligand, which was further enhanced by coculture of these TDLN B cells with 4T1 tumor cells. Effector B cells killed tumor cells directly in vitro in an antigen specific and Fas ligand-dependent manner. Trafficking of TDLN B cells in vivo suggested that they were recruited to the tumor and lung as well as secondary lymphoid organs. These findings further define the biological function of antitumor effector B cells, which may offer alternative cellular therapies to cancer.

摘要

我们之前报道过,在乳腺癌自发性肺转移小鼠模型中,过继转移肿瘤引流淋巴结(TDLN)B细胞可使肿瘤消退。在本研究中,我们在这些B细胞中鉴定出产生白细胞介素10(IL-10)的细胞,并发现通过使用IL-10基因敲除的TDLN B细胞或通过全身性中和IL-10去除IL-10,可显著增强过继转移的TDLN B细胞的治疗效果。在B细胞过继转移中去除IL-10可显著增加受体中PBMC和脾细胞的细胞毒性T淋巴细胞(CTL)及B细胞活性。活化的TDLN B细胞表达Fas配体,这些TDLN B细胞与4T1肿瘤细胞共培养可进一步增强Fas配体的表达。效应B细胞在体外以抗原特异性和Fas配体依赖性方式直接杀伤肿瘤细胞。TDLN B细胞在体内的迁移表明它们被募集到肿瘤、肺以及二级淋巴器官。这些发现进一步明确了抗肿瘤效应B细胞的生物学功能,这可能为癌症提供替代性的细胞疗法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfb2/4414939/15b764fad40d/nihms683271f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfb2/4414939/ed20171de913/nihms683271f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfb2/4414939/0ecc48f46be4/nihms683271f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfb2/4414939/228eb76b9eda/nihms683271f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfb2/4414939/ff1fad7419f4/nihms683271f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfb2/4414939/66ad0982783f/nihms683271f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfb2/4414939/15b764fad40d/nihms683271f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfb2/4414939/ed20171de913/nihms683271f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfb2/4414939/0ecc48f46be4/nihms683271f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfb2/4414939/228eb76b9eda/nihms683271f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfb2/4414939/ff1fad7419f4/nihms683271f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfb2/4414939/66ad0982783f/nihms683271f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfb2/4414939/15b764fad40d/nihms683271f6.jpg

相似文献

1
Antitumor effector B cells directly kill tumor cells via the Fas/FasL pathway and are regulated by IL-10.抗肿瘤效应B细胞通过Fas/FasL途径直接杀伤肿瘤细胞,并受白细胞介素-10调控。
Eur J Immunol. 2015 Apr;45(4):999-1009. doi: 10.1002/eji.201444625. Epub 2015 Jan 21.
2
IL-2 augments the therapeutic efficacy of adoptively transferred B cells which directly kill tumor cells via the CXCR4/CXCL12 and perforin pathways.白细胞介素-2增强了过继转移B细胞的治疗效果,这些B细胞通过CXCR4/CXCL12和穿孔素途径直接杀伤肿瘤细胞。
Oncotarget. 2016 Sep 13;7(37):60461-60474. doi: 10.18632/oncotarget.11124.
3
In vivo sensitized and in vitro activated B cells mediate tumor regression in cancer adoptive immunotherapy.在癌症过继性免疫治疗中,体内致敏和体外活化的B细胞介导肿瘤消退。
J Immunol. 2009 Sep 1;183(5):3195-203. doi: 10.4049/jimmunol.0803773. Epub 2009 Aug 10.
4
Tumor-induced suppression of antitumor reactivity and depression of TCRzeta expression in tumor-draining lymph node lymphocytes: possible relationship to the Th2 pathway.肿瘤诱导的引流肿瘤淋巴结淋巴细胞抗肿瘤反应性抑制及TCRζ表达降低:与Th2途径的可能关系
J Immunother. 1997 Mar;20(2):111-22. doi: 10.1097/00002371-199703000-00003.
5
The Fas/Fas ligand pathway is important for optimal tumor regression in a mouse model of CTL adoptive immunotherapy of experimental CMS4 lung metastases.在实验性CMS4肺转移瘤的CTL过继免疫治疗小鼠模型中,Fas/Fas配体途径对于实现最佳肿瘤消退至关重要。
J Immunol. 2003 Sep 1;171(5):2402-12. doi: 10.4049/jimmunol.171.5.2402.
6
Effect of interleukin-1 alpha on the in vitro activation of tumor-draining lymph node cells for adoptive immunotherapy.白细胞介素-1α对用于过继性免疫治疗的肿瘤引流淋巴结细胞体外活化的影响。
J Immunother Emphasis Tumor Immunol. 1994 Jul;16(1):1-12. doi: 10.1097/00002371-199407000-00001.
7
Synergistic effects of IL-12 and IL-18 in skewing tumor-reactive T-cell responses towards a type 1 pattern.IL-12和IL-18在使肿瘤反应性T细胞反应偏向1型模式方面的协同作用。
Cancer Res. 2005 Feb 1;65(3):1063-70.
8
Tumor-specific CTL kill murine renal cancer cells using both perforin and Fas ligand-mediated lysis in vitro, but cause tumor regression in vivo in the absence of perforin.肿瘤特异性细胞毒性T淋巴细胞(CTL)在体外利用穿孔素和Fas配体介导的细胞溶解作用杀伤小鼠肾癌细胞,但在体内,在没有穿孔素的情况下也能使肿瘤消退。
J Immunol. 2002 Apr 1;168(7):3484-92. doi: 10.4049/jimmunol.168.7.3484.
9
Simultaneous targeting of CD3 on T cells and CD40 on B or dendritic cells augments the antitumor reactivity of tumor-primed lymph node cells.同时靶向T细胞上的CD3和B细胞或树突状细胞上的CD40可增强肿瘤致敏淋巴结细胞的抗肿瘤反应性。
J Immunol. 2005 Aug 1;175(3):1424-32. doi: 10.4049/jimmunol.175.3.1424.
10
Ex vivo stimulation of tumor-draining lymph node cells from lung cancer patients: a potential resource for adoptive immunotherapy.肺癌患者肿瘤引流淋巴结细胞的体外刺激:过继性免疫治疗的潜在资源。
Cell Mol Immunol. 2008 Aug;5(4):307-13. doi: 10.1038/cmi.2008.38.

引用本文的文献

1
Masters of adaptation: How cancer and immune cell plasticity mediates tumor progression.适应大师:癌症与免疫细胞可塑性如何介导肿瘤进展
PLoS Biol. 2025 Jul 15;23(7):e3003301. doi: 10.1371/journal.pbio.3003301. eCollection 2025 Jul.
2
Development of therapeutic cancer vaccines based on cancer immunity cycle.基于癌症免疫循环的治疗性癌症疫苗的开发。
Front Med. 2025 Jul 14. doi: 10.1007/s11684-025-1134-6.
3
Dynamic monitoring of lymphocyte subsets at different disease stages can predict the prognosis of acute myeloid leukemia especially in complete remission status.在不同疾病阶段对淋巴细胞亚群进行动态监测可预测急性髓系白血病的预后,尤其是在完全缓解状态下。
Sci Rep. 2025 May 17;15(1):17128. doi: 10.1038/s41598-025-01600-3.
4
Immune Modulation and Immunotherapy in Solid Tumors: Mechanisms of Resistance and Potential Therapeutic Strategies.实体瘤中的免疫调节与免疫治疗:耐药机制及潜在治疗策略
Int J Mol Sci. 2025 Mar 24;26(7):2923. doi: 10.3390/ijms26072923.
5
Multifaceted function of B cells in tumorigenesis.B细胞在肿瘤发生中的多方面功能。
Front Med. 2025 Apr;19(2):297-317. doi: 10.1007/s11684-025-1127-5. Epub 2025 Mar 22.
6
Tumor-infiltrating and circulating B cells mediate local and systemic immunomodulatory mechanisms in Glioblastoma.肿瘤浸润性和循环性B细胞介导胶质母细胞瘤的局部和全身免疫调节机制。
J Neurooncol. 2025 May;172(3):527-548. doi: 10.1007/s11060-025-04989-z. Epub 2025 Mar 13.
7
Immuno-oncological Challenges and Chemoresistance in Veterinary Medicine: Probiotics as a New Strategic Tool.兽医学中的免疫肿瘤学挑战与化学抗性:益生菌作为一种新的战略工具
Probiotics Antimicrob Proteins. 2025 Feb 15. doi: 10.1007/s12602-025-10468-8.
8
Tumor-Infiltrating Lymphocytes and Neutrophils and Their Location in Canine Mammary Neoplasms with a Solid Arrangement: A Prognostic Factor?肿瘤浸润淋巴细胞和中性粒细胞及其在实体型犬乳腺肿瘤中的位置:一个预后因素?
Animals (Basel). 2025 Jan 20;15(2):287. doi: 10.3390/ani15020287.
9
The current understanding of the phenotypic and functional properties of human regulatory B cells (Bregs).目前对人类调节性B细胞(Bregs)的表型和功能特性的理解。
Oxf Open Immunol. 2024 Sep 20;5(1):iqae012. doi: 10.1093/oxfimm/iqae012. eCollection 2024.
10
Dynamic changes in B cell subpopulations in response to triple-negative breast cancer development.三阴性乳腺癌发生过程中 B 细胞亚群的动态变化。
Sci Rep. 2024 May 21;14(1):11576. doi: 10.1038/s41598-024-60243-y.

本文引用的文献

1
Enhancement of the T-cell armamentarium as a cell-based therapy for prostate cancer.增强 T 细胞武器库作为前列腺癌的细胞治疗方法。
Cancer Res. 2014 Jul 1;74(13):3390-5. doi: 10.1158/0008-5472.CAN-14-0249. Epub 2014 Apr 18.
2
Interleukin-5 supports the expansion of fas ligand-expressing killer B cells that induce antigen-specific apoptosis of CD4(+) T cells and secrete interleukin-10.白细胞介素-5 支持 Fas 配体表达的杀伤 B 细胞的扩增,这些细胞诱导 CD4(+) T 细胞的抗原特异性凋亡,并分泌白细胞介素-10。
PLoS One. 2013 Aug 5;8(8):e70131. doi: 10.1371/journal.pone.0070131. Print 2013.
3
Peritoneal cavity regulatory B cells (B10 cells) modulate IFN-γ+CD4+ T cell numbers during colitis development in mice.腹腔调节性 B 细胞(B10 细胞)可调节结肠炎发展过程中 IFN-γ+CD4+T 细胞的数量。
J Immunol. 2013 Sep 1;191(5):2780-2795. doi: 10.4049/jimmunol.1300649. Epub 2013 Aug 5.
4
Constitutively CD40-activated B cells regulate CD8 T cell inflammatory response by IL-10 induction.持续激活的 CD40 可通过诱导 IL-10 来调节 CD8 T 细胞的炎症反应。
J Immunol. 2013 Apr 1;190(7):3189-96. doi: 10.4049/jimmunol.1203364. Epub 2013 Feb 25.
5
12-Chemokine gene signature identifies lymph node-like structures in melanoma: potential for patient selection for immunotherapy?12-趋化因子基因特征可识别黑色素瘤中的淋巴结样结构:是否有助于免疫治疗患者选择?
Sci Rep. 2012;2:765. doi: 10.1038/srep00765. Epub 2012 Oct 24.
6
Cancer immunotherapy comes of age.癌症免疫疗法崭露头角。
Nature. 2011 Dec 21;480(7378):480-9. doi: 10.1038/nature10673.
7
Multiple mechanisms of immune suppression by B lymphocytes.B 淋巴细胞的多种免疫抑制机制。
Mol Med. 2012 Feb 10;18(1):123-37. doi: 10.2119/molmed.2011.00333.
8
Adoptive transfer of tumor reactive B cells confers host T-cell immunity and tumor regression.过继转移肿瘤反应性 B 细胞可赋予宿主 T 细胞免疫和肿瘤消退。
Clin Cancer Res. 2011 Aug 1;17(15):4987-95. doi: 10.1158/1078-0432.CCR-11-0207. Epub 2011 Jun 20.
9
B regulatory cells and the tumor-promoting actions of TNF-α during squamous carcinogenesis.B 调节细胞和 TNF-α 在鳞状细胞癌变过程中的促肿瘤作用。
Proc Natl Acad Sci U S A. 2011 Jun 28;108(26):10662-7. doi: 10.1073/pnas.1100994108. Epub 2011 Jun 13.
10
B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer.B10 细胞和调节性 B 细胞在炎症、自身免疫和癌症中平衡免疫反应。
Ann N Y Acad Sci. 2010 Jan;1183:38-57. doi: 10.1111/j.1749-6632.2009.05137.x.